Polyunsaturated fatty acid-derived lipid mediator patterns determine viral pneumonia severity and risk for critical COVID-19.

Summary

Using integrated transcriptomic, lipidomic, and immune profiling, the authors show that lipid mediator patterns at hospital admission in COVID-19 correlate with inflammation and stratify severity. Notably, CYP450-derived 20-HETE emerges as a candidate prognostic biomarker for ICU admission and a potential therapeutic target.

Key Findings

• Lipid mediator (LM) patterns at hospital admission are significantly altered in COVID-19 and correlate with inflammatory responses.
• LM profiles stratify patients by disease severity, highlighting CYP450-derived 20-HETE and LOX-associated 15-HETE.
• Elevated 20-HETE is a promising prognostic biomarker for ICU admission and a potential therapeutic target in severe COVID-19.

Clinical Implications

Early lipid mediator profiling could augment severity triage in viral pneumonia/COVID-19 and identify patients who might benefit from therapies modulating CYP450/LOX pathways.

Limitations

• Observational design limits causal inference between lipid mediators and disease severity
• Generalizability and external validation across diverse cohorts are not detailed; no interventional testing

Future Directions

Prospective validation of LM-based prognostic models, interventional trials targeting CYP450/LOX pathways (e.g., 20-HETE modulation), and integration into clinical triage algorithms.